Recruitment of beta-2-glycoprotein 1 to cell surfaces in extrinsic and intrinsic apoptosis

Apoptosis

Volumn 10, Issue 2, 2005, Pages 439-446

  Balasubramanian, K ^a   Maiti, S N ^a   Schroit, A J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Apoptosis; Phagocytosis; Phosphatidylserine

Indexed keywords

BETA2 GLYCOPROTEIN 1; CELL SURFACE PROTEIN; FAS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPATHOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; LIGAND BINDING; MOUSE; MOUSE STRAIN; NICK END LABELING; NONHUMAN; PERITONEAL EXUDATE CELL; PERITONEUM EXUDATE; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SPLEEN; TISSUE SECTION;

ANIMALS; ANNEXIN A5; ANTICOAGULANTS; APOPTOSIS; BETA 2-GLYCOPROTEIN I; CELL MEMBRANE; GLYCOPROTEINS; IN SITU NICK-END LABELING; LIGANDS; MICE; PHAGOCYTES; PHAGOCYTOSIS; PHOSPHATIDYLSERINES; PROTEIN BINDING; SPLEEN;

EID: 18044379136     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10495-005-0817-3     Document Type: Article

References (51)

1. Wajant H. The Fas signaling pathway: More than a paradigm. Science 2002; 296: 1635-1636.
2. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev 2001; 15: 2922-2933.
3. Cai J, Jones DP. Mitochondrial redox signaling during apoptosis. J Bioenerg Biomembr 1999; 31: 327-334.
4. Chandra J, Samali A, Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radic Med 2000; 29: 323-333.
5. Henson PM, Bratton DL, Fadok VA. Apoptotic cell removal. Curr Biol 2001; 11: R795-R805.
6. Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: Clearance of apoptotic cells regulates immune responses. [Review] [125 refs]. Nature Reviews Immunology 2002; 2(12): 965-75.
7. Balasubramanian K, Schroit AJ. Aminophospholipid asymmetry: A matter of life and death. Annu Rev Physiol 2003; 65: 701-734.
8. Ravichandran KS. "Recruitment signals" from apoptotic cells: Invitation to a quiet meal. Cell 2003; 113: 817-820.
9. Arur S, Uche UE, Rezaul K, et al. Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev Cell 2003; 4: 587-598.
10. Kagan VE, Fabisiak JP, Shvedova AA, et al. Oxidative signaling pathway for externalization of plasma membrane phosphatidylserine during apoptosis. FEBS Lett 2000; 477: 1-7.
11. Tyurina YY, Shvedova AA, Kawai K, et al. Phospholipid signaling in apoptosis: Peroxidation and externalization of phosphatidylserine. Toxicology 2000; 148: 93-101.
12. Kagan VE, Gleiss B, Tyurina YY, et al. A role for oxidative stress in apoptosis: Oxidation and externalization of phosphatidylserine is required for macrophage clearance of cells undergoing Fas-mediated apoptosis. Journal of Immunology 2002; 169: 487-499.
13. Verhoven B, Schlegel RA, Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. Journal of Experimental Medicine 1995; 182: 1597-1601.
14. Martin SJ, Reutelingsperger CP, McGahon AJ, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. Journal of Experimental Medicine 1995; 182: 1545-1556.
15. Connor J, Pak CC, Schroit AJ. Exposure of phosphatidylserine in the outer leaflet of human red blood cells. Relationship to cell density, cell age, and clearance by mononuclear cells. J Biol Chem 1994; 269: 2399-2404.
16. 2+ : A control point for apoptosis. Science 2003; 300: 135-139.
17. Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: The calcium-apoptosis link. Nat Rev Mol Cell Biol 2003; 4: 552-565.
18. Platt N, da Silva RP, Gordon S. Recognizing death: The phagocytosis of apoptotic cells. [Review] [59 refs]. Trends in Cell Biology 1998; 8: 365-372.
19. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 2000; 405: 85-90.
20. Grimsley C, Ravichandran KS. Cues for apoptotic cell engulfment: Eat-me, don't eat-me and come-get-me signals. Trends Cell Biol. 2003; 13: 648-656.
21. Chonn A, Semple SC, Cullis PR. Beta 2 glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of "non-self" particles. J Biol Chem 1995; 270: 25845-25849.
22. Dombroski D, Balasubramanian K, Schroit AJ. Phosphatidylserine expression on cell surfaces promotes antibody-dependent aggregation and thrombosis in beta2-glycoprotein I-immune mice. J Autoimmun 2000; 14: 221-229.
23. Fox D, Kouris GJ, Blumofe KA, Heilizer TJ, Husak V, Greisler HP. Optimizing fluorescent labeling of endothelial cells for tracking during long-term studies of autologous transplantation. J Surg Res 1999; 86: 9-16.
24. Cui J, Wahl RL, Shen T, et al. Bone marrow cell trafficking following intravenous administration. Br J Haematol 1999; 107: 895-902.
25. Polz E, Wurm H, Kostner GM. Investigations on beta 2-glycoprotein-I in the rat: Isolation from serum and demonstration in lipoprotein density fractions, Int J Biochem 1980; 11: 265-270.
26. Wurm H. beta 2-Glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles. Int J Biochem 1984; 16: 511-515.
27. Ogasawara J, Watanabe-Fukunaga R, Adachi M, et al. Lethal effect of the anti-Fas antibody in mice. Nature 1993; 364: 806-809.
28. Balasubramanian K, Bevers EM, Willems GM, Schroit AJ. Binding of annexin v to membrane products of lipid peroxidation. Biochemistry 2001; 40: 8672-8676.
29. Steinkasserer A, Estaller C, Weiss EH, Sim RB, Day AJ. Complete nucleotide and deduced amino acid sequence of human beta 2-glycoprotein I. Biochemical Jounal 1991; 277: 387-391.
30. Wang SX, Cai GP, Sui SF. The insertion of huma apolipoprotein H into phospholipid membranes: A monolayer study. Biochemical Journal 1998; 335: 225-232.
31. Wang SX, Cai G, Sui S. Intrinsic fluorescence study of the interaction of human apolipoprotein H with phospholipid vesicles. Biochemistry 1999; 38: 9477-9484.
32. Bouma B, de Groot PG, van den Elsen JM, et al. Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure. EMBO J 1999; 18: 5166-5174.
33. Hammel M, Schwarzenbacher R, Gries A, Kostner GM, Laggner P, Prassl R. Mechanism of the interaction of beta(2)-glycoprotein I with negatively charged phospholipid membranes. Biochemistry 2001; 40: 14173-14181.
34. Brighton TA, Hogg PJ, Dai YP, Murray BH, Chong BH, Chesterman CN. Beta 2-glycoprotein I in thrombosis: Evidence for a role as a natural anticoagulant. Br J Haematol 1996; 93: 185-194.
35. Matsuura E, Igarashi Y, Yasuda T, Triplett DA, Koike T. Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. Journal of Experimental Medicine 1994; 179: 457-462.
36. Schousboe I. Binding of beta 2-glycoprotein I to platelets: Effect of adenylate cyclase activity. Thromb. Res. 1980; 19: 225-237.
37. Ma K, Simantov R, Zhang JC, Silverstein R, Hajjar KA, McCrae KR. High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II. J Biol Chem 2000; 275: 15541-15548.
38. Balasubramanian K, Chandra J, Schroit AJ. Immune clearance of phosphatidylserine-expressing cells by phagocytes. The role of beta2-glycoprotein I in macrophage recognition. J Biol Chem 1997; 272: 31113-31117.
39. Nimpf J, Wurm H, Kostner GM. Beta 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation. Atherosclerosis 1987; 63: 109-114.
40. Nimpf J, Bevers EM, Bomans PH, et al. Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I. Biochim Biophys Acta 1986; 884: 142-149.
41. Balasubramanian K, Schroit AJ. Characterization of phosphatidylserine- dependent beta2-glycop rotem I macrophage interactions. Implications for apoptotic cell clearance by phagocytes. J Biol Chem 1998; 273: 29272-29277.
42. Willems GM, Janssen MP, Pelsers MM, et al. Role of divalency in the high-affinity binding of anticardiolipin antibody-beta 2-glycoprotein I complexes to lipid membranes. Biochemistry 1996; 35: 13833-13842.
43. Hagihara Y, Goto Y, Kato H, Yoshimura T. Role of the N-and C-terminal domains of bovine beta 2-glycoprotein I in its interaction with cardiolipin. Journal of Biochemistry 1995; 118: 129-136.
44. Lutters BC, Derksen RH, Tekelenburg WL, Lenting PJ, Arnout J, de Groot PG. Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2′. J Biol Chem 2003; 278: 33831-33838.
45. Lutters BC, Meijers JC, Derksen RH, Arnout J, de Groot PG. Dimers of beta 2-glycoprotein I mimic the in vitro effects of beta 2-glycoprotein I-anti-beta 2-glycoprotein I antibody complexes. J Biol Chem 2001; 276: 3060-3067.
46. Galazka M, Keil LB, Kohles JD et al. A stable, multi-subunit complex of beta2glycoprotein I. Thromb Res 1998; 90: 131-137.
47. Botto M, Dell'Agnola C, Bygrave AE, et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998; 19: 56-59.
48. Meagher LC, Savill JS, Baker A, Fuller RW, Haslett C. Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2. Journal of Leukocyte Biology 1992; 52: 269-273.
49. Gao Y, HerndonJM, Zhang H, Griffith TS, Ferguson TA. Anti-inflammatory effects of CD95 ligand (FasL)-induced apoptosis. Journal of Experimental Medicine 1998; 188: 887-896.
50. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998; 101: 890-898.
51. Hanayama R, Tanaka M, Miyasaka K, et al. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 2004; 304: 1147-1150.